Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiganxin
- Development stage
- Unknown
- Lead developer
- Wit Dyne Health
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Yiganxin is an oral granule formulation combining glycyrrhizin (glycyrrhizic acid) and zinc, developed and marketed by Wit Dyne Health (Shandong Wit Dyne Health Pharmaceutical Co., Ltd.). It is indicated for liver protection and supportive therapy in patients with various liver diseases. Glycyrrhizin, a triterpenoid saponin derived from licorice root, exerts hepatoprotective effects through anti-inflammatory and antioxidant mechanisms, including the modulation of NF-κB and TLR4 signaling pathways. Zinc is an essential trace element that serves as a cofactor for antioxidant enzyme systems, such as superoxide dismutase, and helps maintain the integrity of hepatocyte membranes. The product is approved in China and is often used as a supportive treatment to reduce liver inflammation and promote tissue repair.
- Brand names
- Yiganxin伊甘欣
- Other names
- Glycyrrhizin zinc granulesGlycyrrhizin + ZincGlycyrrhizin zinc
02
Targets
TLR4 (Toll-like receptor 4)NF-κB
Beyond the preview
Go deeper on Yiganxin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yiganxin.